Idiopathic pulmonary fibrosis overview

Idiopathic pulmonary fibrosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Idiopathic pulmonary fibrosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Idiopathic pulmonary fibrosis overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Idiopathic pulmonary fibrosis overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Idiopathic pulmonary fibrosis overview
CDC on Idiopathic pulmonary fibrosis overview
Idiopathic pulmonary fibrosis overview in the news
Blogs on Idiopathic pulmonary fibrosis overview
Directions to Hospitals Treating Idiopathic pulmonary fibrosis
Risk calculators and risk factors for Idiopathic pulmonary fibrosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Idiopathic Pulmonary Fibrosis (IPF), is a chronic progressive interstitial lung disease of unknown etiology. It is one of the two classic interstitial lung diseases, the other being sarcoidosis.

More specifically, IPF is defined as a distinctive type of chronic fibrosing interstitial pneumonia of unknown cause associated with a histological pattern of usual interstitial pneumonia (UIP).